Sun Pharma Among 9 Drugmakers to Sign Pricing Deals With Trump Administration

India's Sun Pharma and eight other pharmaceutical companies have signed pricing agreements with the Trump administration. The deals are part of the administration's expanding Most-Favoured-Nation (MFN) pricing initiative. The move comes as the Trump team pressures mid-sized drugmakers to align with its preferred pricing framework. The MFN policy aims to ensure the US pays no more for drugs than other countries do.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in